Citation: | WANG Siting, ZHANG Yue, ZHANG Jun, CHENG Zhixin, QI Xue, SUN Lei. Study on medication rules of proven cases of erysipelas based on data mining[J]. Journal of Clinical Medicine in Practice, 2023, 27(10): 21-24, 30. DOI: 10.7619/jcmp.20223610 |
To explore the rules of drug use in treatment of proven cases of erysipelas by data mining.
The Ancient and Modern Medical Records Cloud Platform (version 1.5.6) and Chinese Medical Code (version 5.0) were collected and screened to extract prescriptions. Drug information was collected, and a database was established. The data mining module of the Ancient and Modern Medical Records Cloud Platform (version 1.5.6) was used to analyze drug use frequency and prescription compatibility.
A total of 203 effective prescriptions were selected, including 393 kinds of drugs. The top three frequently used drugs were Chishao, Lianqiao, Mudanpi. Statistical analysis of property, taste and meridian affinity showed that the top three drugs were cold, slightly cold and warm in nature, bitter, sweet and pungent in taste, liver, lung and stomach in meridian affinity. Association rule analysis showed that the drug pair with the highest confidence was Chishao-Mudanpi, and cluster analysis showed that there were 3 categories: cluster 1 category (Lianqiao, Dihuang, Chishao, Mudanpi), cluster 2 category (Danggui, Chuanxiong, Fangfeng, Huangqin, Chaihu) and cluster 3 category (Jinyinhua, Yiyiren, Niuxi, Fuling, Cangzhu, Huangbai). The core formula was obtained by complex network analysis, including 11 drugs (Chishao, Mudanpi, Dihuang, Niuxi, Lianqiao, Huangqin, Huangbai, Yiyiren, Cangzhu, Jinyinhua, Danggui).
The medication rule of proven cases of erysipelas is based on the treatment principle of cooling blood. At the same time, it is necessary to add the drugs with actions of expelling the pathogens by removing dampness, blood stasis and relieving exterior syndrome on the basis of syndrome differentiation, and emphasize on reinforcing healthy qi to deal with priorities.
[1] |
赵辨. 临床皮肤病学[M]. 3版. 南京: 江苏科学技术出版社, 2001: 348-349.
|
[2] |
温国琴. 抗生素耐药性现状及研究进展[J]. 中国处方药, 2022, 20(8): 186-190. doi: 10.3969/j.issn.1671-945X.2022.08.070
|
[3] |
BRINDLE R, WILLIAMS O M, BARTON E, et al. Assessment of antibiotic treatment of cellulitis and erysipelas: a systematic review and meta-analysis[J]. JAMA Dermatol, 2019, 155(9): 1033-1040. doi: 10.1001/jamadermatol.2019.0884
|
[4] |
邵兵. 中医药治疗下肢丹毒研究新进展[J]. 双足与保健, 2018, 27(13): 197-198. https://www.cnki.com.cn/Article/CJFDTOTAL-SZBJ201813107.htm
|
[5] |
何睦, 吴佳豪, 马丽俐. 丹毒源流考[J]. 新中医, 2021, 53(1): 31-34. https://www.cnki.com.cn/Article/CJFDTOTAL-REND202101009.htm
|
[6] |
丁建. 周永坤分期论治丹毒经验[J]. 湖南中医杂志, 2019, 35(4): 38-39. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZO201904018.htm
|
[7] |
范韦佟, 廖彩岑, 周艳, 等. 赤芍的化学成分和抗炎活性研究[J]. 昆明理工大学学报: 自然科学版, 2022, 47(3): 117-122. https://www.cnki.com.cn/Article/CJFDTOTAL-KMLG202203014.htm
|
[8] |
郭宝, 朱向东. 中药连翘化学成分及药理活性最新进展[J]. 化工管理, 2022, (30): 59-61. https://www.cnki.com.cn/Article/CJFDTOTAL-FGGL202230017.htm
|
[9] |
张树蓉, 赵宏苏, 佟沫儒, 等. 牡丹皮化学成分、药理作用及其质量标志物(Q-Marker)的预测分析[J]. 中草药, 2022, 53(16): 5215-5224. doi: 10.7501/j.issn.0253-2670.2022.16.031
|
[10] |
肖石生, 肖群女, 黄清云. 加味赤甘汤治疗外科非特异性感染156例临床观察[J]. 内蒙古中医药, 2012, 31(8): 10-10. https://www.cnki.com.cn/Article/CJFDTOTAL-NZYY201208010.htm
|
[11] |
林皆鹏. 七味消毒饮和退癀散治疗丹毒疗效观察[J]. 皮肤病与性病, 2014, 36(3): 164-165. https://www.cnki.com.cn/Article/CJFDTOTAL-PFBX201403018.htm
|
[12] |
徐春荣. 四妙散合五味消毒饮联合中药外敷治疗丹毒50例[J]. 中国中医药现代远程教育, 2021, 19(21): 89-91. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYY202121036.htm
|
[13] |
肖贤忠. 肖泽梁诊治丹毒经验[J]. 湖南中医杂志, 2019, 35(11): 35-36. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZO201911020.htm
|
1. |
姬林娟,田欣,芮涛,姚永伟. 白细胞与红细胞比容比值对急性ST段抬高型心肌梗死再灌注治疗后院内主要不良心血管事件的预测价值. 实用临床医药杂志. 2024(15): 14-18+25 .
![]() | |
2. |
莫妮娜. 冠心病冠状动脉介入术患者心功能改变及相关影响因素. 吉林医学. 2022(11): 2943-2946 .
![]() |